Literature DB >> 20625656

Concomitant thyroid Malt lymphoma and papillary thyroid carcinoma.

Giulianno Molina de Melo1, Danilo Anunciatto Sguilar, Cyntia Moniz Figueira Petiti, André Gustavo Gumz Eichstaedt, Rogério Ramos Caiado, Ricardo Antenor de Souza E Souza.   

Abstract

The objective of this study was to describe the rare thyroid MALT lymphoma concomitant with papillary thyroid carcinoma in a male patient who was submitted to total thyroidectomy. Treatment and follow-up issues are addressed. Male patient complains of fast thyroid enlargement without lymphadenophaty and normal clinical exams. Total thyroidectomy was indicated and performed without any complications. The pathology showed multicentric papillary thyroid carcinoma, concomitant thyroid MALT lymphoma and Hashimoto's thyroiditis. The immunohistochemistry assay was positive for CD 20, CD 43, CD 79, AE1/AE3. The staging studies showed no evidence of both metastasis, Ann Harbor stage IE, without B symptoms. After RIT no further radiotherapy or chemotherapy was indicated. Nowadays the thyroglobulin is undetectable, without recurrences at two years of follow-up. It was concluded that primary thyroid MALT lymphoma is uncommon being the papillary thyroid carcinoma more frequent. Both occurring concomitantly is very rare and the treatment has to prioritize the tumor of worst prognosis at the discovery moment.

Entities:  

Mesh:

Year:  2010        PMID: 20625656     DOI: 10.1590/s0004-27302010000400013

Source DB:  PubMed          Journal:  Arq Bras Endocrinol Metabol        ISSN: 0004-2730


  9 in total

1.  Hashimotos Thyroiditis with Coexistent Papillary Carcinoma and Non-hodgkin Lymphoma-thyroid.

Authors:  Ks Jayaprakash; Hl Kishanprasad; P Hegde; R Chandrika
Journal:  Ann Med Health Sci Res       Date:  2014-03

Review 2.  Mucosa-Associated Lymphoid Tissue Lymphoma of the Thyroid Gland: A Systematic Review of the Literature.

Authors:  Evangelos Karvounis; Ioannis Kappas; Anna Angelousi; Georgios-Marios Makris; Eva Kassi
Journal:  Eur Thyroid J       Date:  2019-11-18

Review 3.  Role of Helicobacter pylori in gastric mucosa-associated lymphoid tissue lymphomas.

Authors:  Marta-Isabel Pereira; José Augusto Medeiros
Journal:  World J Gastroenterol       Date:  2014-01-21       Impact factor: 5.742

4.  Synchronous Presence of Nasopharyngeal Carcinoma and Marginal Zone (MALT-Type) B-Cell Lymphoma in the Pharynx.

Authors:  Triantafyllia Koletsa; Georgios Petrakis; Georgia Karayannopoulou; Dimitrios Pappas; Konstantinos Markou; Georgios Karkavelas; Ioannis Kostopoulos
Journal:  Patholog Res Int       Date:  2011-05-31

5.  Rare case of male breast cancer and axillary lymphoma in the same patient: an unique case report.

Authors:  Emiliano Sordi; Katia Cagossi; Maria Grazia Lazzaretti; Daniel Gusolfino; Fabrizio Artioli; Giovanni Santacroce; Maria Luisa Brandi; Prisco Piscitelli
Journal:  Case Rep Med       Date:  2011-10-11

6.  Primary mucosa-associated lymphoid tissue thyroid lymphoma: a rare thyroid neoplasm of extrathyroid origin.

Authors:  Melpomeni Peppa; Panagiotis Nikolopoulos; Penelope Korkolopoulou; Dimitrios Lapatsanis; George Dimitriadis; Dimitrios Hadjidakis; Sotirios A Raptis
Journal:  Rare Tumors       Date:  2012-01-19

7.  Co-occurrence of papillary thyroid carcinoma and mucosa-associated lymphoid tissue lymphoma in a patient with long-standing hashimoto thyroiditis.

Authors:  Yoon Jeong Nam; Bo Hyun Kim; Seong Keun Lee; Yun Kyung Jeon; Sang Soo Kim; Woo Jin Jung; Dong Hwahn Kahng; In Ju Kim
Journal:  Endocrinol Metab (Seoul)       Date:  2013-12-12

8.  Co-occurrence of papillary thyroid cancer and MALT lymphoma of the thyroid with severe airway obstruction: A case report and review of the literature.

Authors:  Tatsuya Tarui; Norihiko Ishikawa; Shinichi Kadoya; Go Watanabe
Journal:  Int J Surg Case Rep       Date:  2014-06-05

9.  Cytodiagnosis of Primary Thyroid Lymphoma Coincident with Unnoticed Papillary Thyroid Carcinoma: A Case Report and Review of the Literature.

Authors:  Gozde Kir; Billur Cosan Sarbay; Adnan Ozpek
Journal:  J Cytol       Date:  2018 Jul-Sep       Impact factor: 1.000

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.